文献速递复苏、休克与脓毒症

派遣公民急救志愿者应对院外心脏骤停:系统评价与Meta分析

Dispatching citizens as first responders to out-of-hospital cardiac arrests: a systematic review and meta-analysis.
PubMed 文献 · Eur J Emerg Med · 2022-03-10
一句话结论激活公民急救志愿者与院外心脏骤停患者 bystander 心肺复苏率、AED 使用率及出院或30天生存率升高相关,但与神经功能完好出院率无显著相关。

该系统评价与Meta分析检索PubMed、EMBASE和Cochrane对照试验中心注册库(截至2021年11月24日),纳入10项比较公民急救志愿者激活与标准应急响应的研究,共23 351例院外心脏骤停患者。主要终点为出院或30天生存率,激活组903/9978(9.1%)vs 标准组1104/13 247(8.3%),OR 1.45(95%CI 1.21-1.74,P<0.001)。次要终点中,自主循环恢复率、bystander启动心肺复苏率、AED使用率均显著升高,但神经功能完好出院率无显著差异。证据确定性采用GRADE评价。

要点

  • 激活公民急救志愿者组出院或30天生存率9.1%(903/9978)vs 标准应急响应组8.3%(1104/13 247),OR 1.45(95%CI 1.21-1.74,P<0.001)。
  • 激活组bystander启动心肺复苏率65%(5876/9074)vs 53%(6384/11 970),OR 1.75(95%CI 1.43-2.15,P<0.001)。
  • 激活组救护车到达前AED使用率7.2%(654/9132)vs 4.2%(624/14 848),OR 1.82(95%CI 1.31-2.53,P<0.001)。
  • 激活组自主循环恢复率28%(2575/9169)vs 27%(3445/12 607),OR 1.40(95%CI 1.07-1.81,P=0.01)。
  • 神经功能完好出院率12%(316/2685)vs 9.3%(276/2972),OR 1.37(95%CI 0.81-2.33,P=0.24),未达统计学显著。

适用人群与场景

  • 院外心脏骤停(OHCA)患者,比较公民急救志愿者激活与标准应急响应的研究人群。

研究设计与关键结果

  • 系统评价与Meta分析,检索PubMed、EMBASE和Cochrane对照试验中心注册库(截至2021年11月24日),初检1215篇,最终纳入10项研究共23 351例患者。
  • 主要终点出院或30天生存率:激活组9.1%(903/9978)vs 标准组8.3%(1104/13 247),OR 1.45(95%CI 1.21-1.74,P<0.001)。
  • 自主循环恢复率:激活组28%(2575/9169)vs 标准组27%(3445/12 607),OR 1.40(95%CI 1.07-1.81,P=0.01)。
  • bystander启动心肺复苏率:激活组65%(5876/9074)vs 标准组53%(6384/11 970),OR 1.75(95%CI 1.43-2.15,P<0.001)。
  • 救护车到达前AED使用率:激活组7.2%(654/9132)vs 标准组4.2%(624/14 848),OR 1.82(95%CI 1.31-2.53,P<0.001)。
  • 神经功能完好出院率:激活组12%(316/2685)vs 标准组9.3%(276/2972),OR 1.37(95%CI 0.81-2.33,P=0.24),未达统计学显著。
  • 证据确定性采用GRADE评价。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析(纳入10项研究,共23 351例患者)。
  • 证据确定性采用GRADE评价。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,向院外心脏骤停患者派遣公民急救志愿者与更高的bystander启动心肺复苏率、救护车到达前AED使用率及出院或30天生存率相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Mobile phone technologies to alert citizen first responders to out-of-hospital cardiac arrests (OHCAs) were implemented in numerous countries. This systematic review and meta-analysis aim to investigate whether activating citizen first responders increases bystanders' interventions and improves outcomes. We searched PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from inception to 24 November 2021, for studies comparing citizen first responders' activation versus standard emergency response in the case of OHCA. The primary outcome was survival at hospital discharge or 30 days. Secondary outcomes were discharge with favourable neurological outcome, bystander-initiated cardiopulmonary resuscitation (CPR), and the use of automated external defibrillators (AEDs) before ambulance arrival. Evidence certainty was evaluated with GRADE. Our search strategy yielded 1215 articles. After screening, we included 10 studies for a total of 23 351 patients. OHCAs for which citizen first responders were activated had higher rates of survival at hospital discharge or 30 days compared with standard emergency response [nine studies; 903/9978 (9.1%) vs. 1104/13 247 (8.3%); odds ratio (OR), 1.45; 95% confidence interval (CI), 1.21-1.74; P < 0.001], return of spontaneous circulation [nine studies; 2575/9169 (28%) vs. 3445/12 607 (27%); OR, 1.40; 95% CI, 1.07-1.81; P = 0.01], bystander-initiated CPR [eight studies; 5876/9074 (65%) vs. 6384/11 970 (53%); OR, 1.75; 95% CI, 1.43-2.15; P < 0.001], and AED use [eight studies; 654/9132 (7.2%) vs. 624/14 848 (4.2%); OR, 1.82; 95% CI, 1.31-2.53; P < 0.001], but similar rates of neurological intact discharge [three studies; 316/2685 (12%) vs. 276/2972 (9.3%); OR, 1.37; 95% CI, 0.81-2.33; P = 0.24]. Alerting citizen first responders to OHCA patients is associated with higher rates of bystander-initiated CPR, use of AED before ambulance arrival, and survival at hospital discharge or 30 days.

来源:Eur J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Scquizzato T, Belloni O, Semeraro F, et al. Dispatching citizens as first responders to out-of-hospital cardiac arrests: a systematic review and meta-analysis. Eur J Emerg Med. 2022. PMID: 35283448. doi:10.1097/MEJ.0000000000000915

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。